$1.66 Billion Fecal Occult Testing Markets - Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts to 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Fecal Occult Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global fecal occult testing market size reached US$ 1,231.90 Million in 2021. Looking forward, the market is set to reach US$ 1,663.40 Million by 2027, exhibiting a CAGR of 5.13% during 2021-2027.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The rising focus on integrated health services for improved patient experience and health outcomes, in confluence with the increasing inclination towards point-of-care diagnostics (POCD), represents one of the key factors stimulating the market growth.

Apart from this, the rising geriatric population is accelerating the growth of the market as the risk of contracting diseases increases with age. As a result, governing agencies of various countries are implementing several FOBT screening programs for older adults.

Furthermore, the widespread adoption of minimally invasive (MI) procedures is contributing to the growth of the market. Besides this, immunochemical fecal occult blood tests (iFOBTs or FITs) are gaining traction as they are easy to use and clinically more sensitive to cancers and advanced adenomas.

The easy availability of FOBT devices at online retail stores is anticipated to create a positive impact on the market growth in the upcoming years.

Key Questions Answered in This Report:

• How has the global fecal occult testing market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global fecal occult testing market?
• What are the key regional markets?
• What is the breakup of the market based on the test type?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global fecal occult testing market and who are the key players?
• What is the degree of competition in the industry?

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

• Abbott Laboratories
• Beckman Coulter Inc. (Danaher Corporation)
• Biohit Oyj
• EDP Biotech Corporation
• Eiken Chemical Co. Ltd.
• Epigenomics AG
• Quest Diagnostics Incorporated
• Quidel Corporation
• Randox Laboratories Ltd.

Key Market Segmentation:

Breakup by Test Type:

• Guaiac FOB Stool Test
• Immuno-FOB Agglutination Test
• Lateral Flow Immuno-FOB Test
• Immuno-FOB ELISA Test

Breakup by End User:

• Hospitals
• Clinical Diagnostic Laboratories
• Physician Office Laboratories

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

For more information about this report visit https://www.researchandmarkets.com/r/91po17

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.